News
BIOMARK PROVIDES BUSINESS UPDATE AND SECOND QUARTER Financial RESULTS
BIOMARK PROVIDES BUSINESS UPDATE AND SECOND QUARTER Financial RESULTS Vancouver, British Columbia – (November 28,
November 29, 2022
Menu
Menu
- Articles and Information
- February 23, 2016
Dr James Bond on Biomark
BioMark Diagnostics Inc.
BioMark Diagnostics is leading the world in early-stage cancer detection with an oncology focus designed to improve patient outcomes.
Categories
Archives
Sign up for the latest Biomark news
No paperwork, no hassle. We keep things digital, easy and regular.
*Zero Spam Policy. You will need to confirm your email address to receive our news to your inbox.
Related articles ...
Articles and Information
Form 7 Monthly Progress Report October 1 2022
Form 7 Monthly Progress Report November 1, 2022 Name of Listed Issuer: Trading Symbol: Number
November 1, 2022
News
BIOMARK’s GLIOBLASTOMA Study Published in CANCERS Demonstrates Inhibiting SAT1 sensitized cancer cells towards radiation and chemotherapy
BIOMARK’s GLIOBLASTOMA Study Published in CANCERS Demonstrates Inhibiting SAT1 Sensitized Cancer Cells Towards Radiation and
October 30, 2022
Articles and Information
Form 7 Monthly Progress Report – September 2022
Form 7 Monthly Progress Report – August 2022 Name of Listed Issuer: Trading Symbol: Number
October 2, 2022
News
The US Patent Office Grants BIOMARK Additional Patent for its LIQUID BIOPSY Technology
THE US PATENT OFFICE GRANTS BIOMARK ADDITIONAL PATENT FOR ITS LIQUID BIOPSY TECHNOLOGY Vancouver, British
September 23, 2022
1 604 370 0779
130 3851 Shell Road
Richmond BC
Canada V6X 2W2
Pages
Menu
Latest Posts
Menu
Site Policies
Menu